Trovagene Inc (NASDAQ:TROV)

0.785
Delayed Data
As of Jul 20
 +0.035 / +4.67%
Today’s Change
0.72
Today|||52-Week Range
13.32
-78.73%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.75
Today’s open0.76
Day’s range0.74 - 0.82
Volume2,883,190
Average volume (3 months)509,490
Market cap$46.6M
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+47.45%
Earnings growth (this year)+81.48%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+32.63%
P/E ratioNM
Price/Sales21.10
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
MBOTMicrobot Medical Inc-0.00-0.45%
ONCSOncoSec Medical Inc+0.04+3.13%
PTIProteostasis Therape...-0.05-1.80%
--BARD1 Life Sciences ...+0.00+14.29%
Data as of 4:00pm ET, 07/20/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$505.4K
Annual profit (last year)-$24.9M
Net profit margin-4,928.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Thomas H. Adams
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts